Compatibility of Zofran (Ondansetron) and Bentyl (Dicyclomine)

Mechanism of Action and Uses

• Ondansetron (Zofran) is a selective serotonin 5-HT3 receptor antagonist primarily used to prevent nausea and vomiting, especially in chemotherapy, radiation therapy, and post-operative settings 1, 2

Safety of Combination

• There are no documented significant drug interactions between ondansetron and dicyclomine in the clinical guidelines reviewed 1, 2, 3
• Neither medication appears on contraindication lists for the other in the available guidelines 2, 3

Pharmacokinetic Considerations

• When considering drug combinations, it's essential to evaluate potential pharmacokinetic and pharmacodynamic interactions, which do not appear significant between these medications 4

Clinical Considerations

• If nausea persists despite ondansetron, adding medications with different mechanisms of action (like dicyclomine for its antispasmodic effects) follows recommended practice for managing persistent symptoms, as suggested by the American Society of Clinical Oncology 5

Dosing Considerations

• Standard dosing for ondansetron is 8 mg orally or 0.15 mg/kg IV for prevention of nausea and vomiting, according to the National Comprehensive Cancer Network 2
• No dosage adjustments are required when these medications are used together 2